Understanding long-term cancer survival in hard-to-treat tumors
Part of Cancer, Lungs & breathing clinical trials.
This study looks at why some people with hard-to-treat cancers live much longer than expected. It collects tumor samples to search for clues that might help future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have one of these cancers that has spread: pancreatic cancer, a type of brain tumor (glioblastoma), or a type of lung cancer (extensive small cell).
- You have lived a very long time with this cancer: at least 5 years for pancreatic or lung cancer, or at least 3 years for glioblastoma.
- At least one of your tumor samples is available for testing, and it was collected at least 5 years ago (for pancreatic or lung) or 3 years ago (for glioblastoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients with advanced non-small cell lung cancer who received immunotherapy (immune checkpoint inhibitors) alone or in combination with other treatments. It aims to understand why some patients survive longer than others by analyzing their medical data and using AI to predict outcomes.
This study looks at people who have lived more than three years with advanced lung cancer (non-small cell or small cell) that has spread. The goal is to better understand why some people do well for a long time and how to help more patients.
This study uses advanced testing (molecular profiling and imaging) to better understand cancers and help guide treatment. It is for people with certain advanced cancers who have not yet had immunotherapy or targeted therapy.
This trial tests treatments that are chosen specifically for you based on the genetic makeup of your tumor. The goal is to find a targeted therapy that may work better for your advanced pancreatic cancer after standard chemotherapy has stopped being effective.
This study looks at advanced or metastatic pancreatic cancer patients and uses stored tumor tissue to learn what may predict treatment outcomes. You may be able to join if you have had limited prior chemotherapy and can provide an archived tissue sample.
This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.
Hear when a new Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.